Health Canada approves RSV vaccine for maternal immunization
Health Canada has approved a new Respiratory Syncytial Virus (RSV) vaccine geared toward protecting two of the groups most severely affected by the virus: newborns, who would receive antibodies through maternal immunization, and Canadians over 60.
![Health Canada approves RSV vaccine for maternal immunization](https://i.cbc.ca/1.6097854.1701210554!/fileImage/httpImage/image.jpg_gen/derivatives/16x9_620/health-worker.jpg)
![Provincial officials said this week that they hope to include more family care practitioners in the immunization campaign in an effort to reach residents still without first doses and slowly shift away from mass clinics. A person wearing a medical mask draws liquid from a vial with a syringe. Their face is visible from profile.](https://i.cbc.ca/1.6097854.1701210554!/fileImage/httpImage/image.jpg_gen/derivatives/16x9_620/health-worker.jpg)
Health Canada has approved a new Respiratory Syncytial Virus (RSV) vaccine geared toward protecting two of the groups most severely affected by the virus: newborns, who would receive antibodies through maternal immunization, and Canadians over 60.